50 Participants Needed

Transcranial Ultrasound for Cranioplasty

NB
TW
Overseen ByTamika Wong, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Northwell Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to gather real-world evidence on using transcranial ultrasound through a special type of skull reconstruction called sonolucent cranioplasty. It focuses on patients already undergoing this specific type of cranioplasty to evaluate the effectiveness of ultrasound imaging in these cases. Participants should be adults receiving this skull surgery as part of their regular medical care. As an unphased trial, the study offers patients the opportunity to contribute to innovative research that could enhance future medical procedures.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that transcranial ultrasound is safe for cranioplasty?

Research has shown that transcranial ultrasound, used in various medical settings, is generally easy for patients to handle. Studies have found it to be a non-invasive and helpful tool for assessing brain conditions. Many doctors frequently use it in emergency care and to evaluate brain injuries. Patients might feel slight discomfort or pressure where the ultrasound is applied, but serious side effects are rare. Importantly, the FDA has approved the ultrasound devices used in this study, and they are commonly used in medical practice, suggesting that the treatment is safe.12345

Why are researchers excited about this trial?

Researchers are excited about using transcranial ultrasound for cranioplasty because it offers a non-invasive imaging option that can potentially improve surgical outcomes. Unlike traditional methods, which may rely heavily on CT or MRI for imaging, transcranial ultrasound provides real-time, dynamic images without exposing patients to radiation. This approach could make surgeries safer and more efficient by allowing surgeons to monitor and adjust procedures on the fly. Additionally, it uses FDA-approved ultrasound devices that are already trusted in clinical practice, potentially making it a more accessible and cost-effective alternative.

What evidence suggests that transcranial ultrasound is effective for cranioplasty?

Research has shown that transcranial ultrasound, which participants in this trial will receive, can enhance brain function after cranioplasty, a surgery to repair the skull. Studies have found that this method safely tracks changes in blood flow to the brain, which is crucial for recovery. In individuals with traumatic brain injuries, transcranial ultrasound has proven beneficial for both immediate and long-term care. Evidence suggests that using ultrasound during cranioplasty may improve recovery by boosting blood flow and aiding brain healing.13467

Who Is on the Research Team?

NB

Netanel Ben-Shalom, MD

Principal Investigator

Lenox Hill Hospital

Are You a Good Fit for This Trial?

This trial is for men and women aged 18 or older who are undergoing reconstructive sonolucent cranioplasty as standard care. Participants must be willing to follow study procedures and be available for the entire study duration. Pregnant individuals cannot participate.

Inclusion Criteria

You have provided a signed and dated declaration of consent.
I am having a skull reconstruction with a transparent implant as part of my treatment.
I am willing and able to follow all study rules and attend all appointments.

Exclusion Criteria

Patients who are pregnant

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Ultrasound imaging performed using FDA-approved devices to assess feasibility and efficacy compared to standard postoperative imaging

12 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Transcranial Ultrasound
Trial Overview The trial is observing how transcranial ultrasound works when used through a sonolucent (sound-transparent) material during cranioplasty, which is skull reconstruction surgery. It's an open-label study, meaning everyone knows what treatment they're getting.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Transcranial UltrasoundExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwell Health

Lead Sponsor

Trials
481
Recruited
470,000+

Published Research Related to This Trial

Using 3-dimensional graphical reconstructions of patients' skulls can significantly improve the success rates of transcranial Doppler ultrasound (TCD) procedures performed post-surgery, especially in challenging cases.
The image guidance not only enhances operator confidence but also reduces the time needed to complete the TCD, making it a valuable tool in postoperative care.
Image guidance for rapid temporal acoustic window localisation prior to transcranial Doppler ultrasound in the neurosurgical patient.Lewis, PM., Goldschlager, T., Rosenfeld, JV.[2016]
Decompressive craniectomy (DC) significantly reduces intracranial pressure (ICP) from an average of 37 mm Hg to 20 mm Hg immediately after the procedure, indicating its efficacy in managing severe traumatic brain injury (TBI).
The procedure also leads to improved cerebral blood flow, with diastolic velocities increasing and pulsatility index decreasing, suggesting a normalization of cerebral hemodynamics that lasts for at least 48 hours post-surgery.
Cerebral hemodynamic changes in severe head injury patients undergoing decompressive craniectomy.Daboussi, A., Minville, V., Leclerc-Foucras, S., et al.[2010]
Transcranial Doppler ultrasonography (TCD) is an effective tool for assessing changes in cerebral blood flow, which is crucial for understanding both normal and abnormal brain function.
TCD can be used to measure cerebrovascular reactivity in response to various physiological and pathological stimuli, highlighting its importance in clinical evaluations.
[Investigation of cerebrovascular reactivity using transcranial doppler ultrasonography].Sapieja, W.[2015]

Citations

Transcranial ultrasound in the critically ill patientIn this review, we discuss some important origins of more modern composite techniques and highlight relevant major key concepts, whilst noting ...
Clinical study Neurological improvement after cranioplastyPostoperative changes in neurological status and blood flow velocity were examined and compared using transcranial Doppler (TCD) sonography. The mean interval ...
Transcranial Doppler Ultrasound Role for Patients with ...This review summarizes the advantages and the specific roles of TCD ultrasonography for patients with acute and long-term effects of TBI. Key ...
Technical Considerations in the TCD Evaluation of Cerebral ...Transcranial Doppler ultrasound (TCD) has been recommended as an ancillary test; however, the technical descriptions have been heterogeneous.
Transcranial Ultrasound for CranioplastyTranscranial Doppler sonography (TCD) proved to be an effective noninvasive method for monitoring changes in cerebral blood flow, demonstrating that surgery ...
Role of Bedside Transcranial Ultrasonography in the...Studies on Cranioplasty and Transcranial Doppler. Clinical, neurological, and cognitive outcomes were assessed by the Glasgow Outcome Scale (GOS). Majority ...
Transcranial sonography: practical use in the intensive ...Brain ultrasonography has emerged as a valuable diagnostic and monitoring tool in intensive care, complementing other point-of-care techniques.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security